HuGE Literature Finder
Records 1-30
|
Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy.
Journal of translational medicine 2021 Jan 19 (1): 7. Kim Seongyeong, Shin Dongjin, Min Ahrum, Kim Minjung, Na Deukchae, Lee Han-Byeol, Ryu Han Suk, Yang Yaewon, Woo Go-Un, Lee Kyung-Hun, Lee Dae-Won, Kim Tae-Yong, Lee Charles, Im Seock-Ah, Kim Jong- |
|
PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing.
Breast cancer (Tokyo, Japan) 2021 Jan . Jia Minghan, Liao Ning, Chen Bo, Zhang Guochun, Wang Yulei, Li Xuerui, Cao Li, Mok Hsiaopei, Ren Chongyang, Li Kai, Li Cheukfai, Wen Lingzhu, Lin Jiali, Wei Guangnan, Balch Charles |
|
Alpelisib Plus Fulvestrant for PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Advanced Breast Cancer: Final Overall Survival Results From SOLAR-1.
Annals of oncology : official journal of the European Society for Medical Oncology 2020 Nov . André F, Ciruelos E M, Juric D, Loibl S, Campone M, Mayer I A, Rubovszky G, Yamashita T, Kaufman B, Lu Y-S, Inoue K, Pápai Z, Takahashi M, Ghaznawi F, Mills D, Kaper M, Miller M, Conte P F, Iwata H, Rugo H |
|
Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA).
Breast cancer research and treatment 2020 Nov . Clifton Katherine, Luo Jingqin, Tao Yu, Saam Jennifer, Rich Thereasa, Roshal Anna, Frith Ashley, Rigden Caron, Ademuyiwa Foluso, Weilbaecher Katherine, Hernandez-Aya Leonel, Peterson Lindsay L, Bagegni Nusayba, Suresh Rama, Bose Ron, Opyrchal Mateusz, Wildes Tanya M, Ma Cynth |
|
Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.
Breast cancer research : BCR 2020 Oct 22 (1): 107. Fumagalli Caterina, Ranghiero Alberto, Gandini Sara, Corso Federica, Taormina Sergio, De Camilli Elisa, Rappa Alessandra, Vacirca Davide, Viale Giuseppe, Guerini-Rocco Elena, Barberis Massi |
|
Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
Breast cancer research : BCR 2020 Aug 22 (1): 91. van Geelen Courtney T, Savas Peter, Teo Zhi Ling, Luen Stephen J, Weng Chen-Fang, Ko Yi-An, Kuykhoven Keilly S, Caramia Franco, Salgado Roberto, Francis Prudence A, Dawson Sarah-Jane, Fox Stephen B, Fellowes Andrew, Loi Shere |
|
Induction of PIK3CA alterations during neoadjuvant letrozole may improve outcome in postmenopausal breast cancer patients.
Breast cancer research and treatment 2020 Aug . Skriver Signe Korsgaard, Jensen Maj-Britt, Eriksen Jens-Ole, Ahlborn Lise Barlebo, Knoop Ann Soegaard, Rossing Maria, Ejlertsen Bent, Laenkholm Anne-Vibe |
|
PIK3CA mutation in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer: association with prognosis and integration with PAM50 subtype.
Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Aug . Guarneri Valentina, Dieci Maria Vittoria, Bisagni Giancarlo, Brandes Alba A, Frassoldati Antonio, Cavanna Luigi, Musolino Antonino, Giotta Francesco, Rimanti Anita, Garrone Ornella, Bertone Elena, Cagossi Katia, Nanni Oriana, Piacentini Federico, Orvieto Enrico, Griguolo Gaia, Curtarello Matteo, Urso Loredana, Paré Laia, Chic Nuria, D'Amico Roberto, Prat Aleix, Conte PierFran |
|
Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy.
Breast cancer research and treatment 2020 Jul . Li Kai, Liao Ning, Chen Bo, Zhang Guochun, Wang Yulei, Guo Liping, Wei Guangnan, Jia Minghan, Wen Lingzhu, Ren Chongyang, Cao Li, Mok Hsiaopei, Li Cheukfai, Lin Jiali, Chen Xiaoqing, Zhang Zhou, Hou Ting, Li Min, Liu Jing, Balch Charles M, Liao Ni |
|
Landscape of circulating tumour DNA in metastatic breast cancer.
EBioMedicine 2020 Jul 58 102914. Davis Andrew A, Jacob Saya, Gerratana Lorenzo, Shah Ami N, Wehbe Firas, Katam Neelima, Zhang Qiang, Flaum Lisa, Siziopikou Kalliopi P, Platanias Leonidas C, Gradishar William J, Behdad Amir, Cristofanilli Massi |
|
Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 Jun . Sun Xiangjie, Zuo Ke, Yao Qianlan, Zhou Shuling, Shui Ruohong, Xu Xiaoli, Bi Rui, Yu Baohua, Cheng Yufan, Tu Xiaoyu, Lu Hongfen, Yang Went |
|
Frequency and spectrum of PIK3CA somatic mutations in breast cancer.
Breast cancer research : BCR 2020 May 22 (1): 45. Martínez-Sáez Olga, Chic Nuria, Pascual Tomás, Adamo Barbara, Vidal Maria, González-Farré Blanca, Sanfeliu Esther, Schettini Francesco, Conte Benedetta, Brasó-Maristany Fara, Rodríguez Adela, Martínez Débora, Galván Patricia, Rodríguez Ana Belén, Martinez Antonio, Muñoz Montserrat, Prat Ale |
|
High levels of chromosomal copy number alterations and TP53 mutations correlate with poor outcome in younger breast cancer patients.
The American journal of pathology 2020 May . Koçak Ayla, Heselmeyer-Haddad Kerstin, Lischka Annette, Hirsch Daniela, Fiedler David, Hu Yue, Doberstein Natalie, Torres Irianna, Chen Wei-Dong, Gertz E Michael, Schäffer Alejandro A, Freitag-Wolf Sandra, Kirfel Jutta, Auer Gert, Habermann Jens K, Ried Thom |
|
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy.
Translational oncology 2020 May 13 (9): 100794. Omarini Claudia, Bettelli Stefania, Manfredini Samantha, Barbolini Monica, Isca Chrystel, Cortesi Giulia, Maiorana Antonino, Tazzioli Giovanni, Dominici Massimo, Piacentini Federi |
|
Somatic mutations of triple-negative breast cancer: a comparison between Black and White women.
Breast cancer research and treatment 2020 May . Omilian Angela R, Wei Lei, Hong Chi-Chen, Bandera Elisa V, Liu Song, Khoury Thaer, Ambrosone Christine B, Yao So |
|
Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression.
Cancer medicine 2020 Apr . Welt Anja, Wiesweg Marcel, Theurer Sarah, Abenhardt Wolfgang, Groschek Matthias, Müller Lothar, Schröder Jan, Tewes Mitra, Chiabudini Marco, Potthoff Karin, Bankfalvi Agnes, Marschner Norbert, Schuler Martin, Breitenbücher Fra |
|
Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer.
BMC cancer 2020 Apr 20 (1): 347. McCarthy Anne Marie, Kumar Nitya Pradeep, He Wei, Regan Susan, Welch Michaela, Moy Beverly, Iafrate A John, Chan Andrew T, Bardia Aditya, Armstrong Katri |
|
Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 Mar . Beca Francisco, Krings Gregor, Chen Yunn-Yi, Hosfield Elizabeth M, Vohra Poonam, Sibley Richard K, Troxell Megan L, West Robert B, Allison Kimberly H, Bean Gregory |
|
Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer.
Breast cancer research and treatment 2020 Feb . Shibayama Tomoko, Low Siew-Kee, Ono Makiko, Kobayashi Takayuki, Kobayashi Kokoro, Fukada Ippei, Ito Yoshinori, Ueno Takayuki, Ohno Shinji, Nakamura Yusuke, Takahashi Shun |
|
PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane-Based Neoadjuvant Chemotherapy.
Cancer research and treatment : official journal of Korean Cancer Association 2020 Feb . Guo Sanxing, Loibl Sibylle, Minckwitz Gunter von, Darb-Esfahani Silvia, Lederer Bianca, Denkert Carst |
|
Genomic profiling of multiple breast cancer reveals inter-lesional heterogeneity.
British journal of cancer 2020 Jan . Ahn Soomin, Kim Hyun Jeong, Kang Eunyoung, Kim Eun-Kyu, Kim Se Hyun, Kim Jee Hyun, Kim In Ah, Park So Ye |
|
Heterogeneity of genomic profile in patients with HER2-positive breast cancer.
Endocrine-related cancer 2020 Jan . Chen Bo, Zhang Guochun, Wei Guangnan, Wang Yulei, Guo Liping, Lin Jiali, Li Kai, Mok Hsiaopei, Cao Li, Ren Chongyang, Wen Lingzhu, Jia Minghan, Li Cheukfai, Hou Ting, Zhang Hanhan, Liu Jing, Balch Charles M, Liao Ni |
|
Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients.
BMC cancer 2020 Jan 20 (1): 72. Manoharan Vahinipriya, Karunanayake Eric Hamilton, Tennekoon Kamani Hemamala, De Silva Sumadee, Imthikab Ahamed Ilyas Ahamed, De Silva Kanishka, Angunawela Preethika, Vishwakula Sameera, Lunec Jo |
|
The association of modifiable breast cancer risk factors and somatic genomic alterations in breast tumors: The Cancer Genome Atlas Network.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 Jan . Heng Yujing J, Hankinson Susan E, Wang Jun, Alexandrov Ludmil B, Ambrosone Christine B, Andrade Victor Piana de, Brufsky Adam M, Couch Fergus J, King Tari A, Modugno Francesmary, Vachon Celine M, Eliassen A Heather, Tamimi Rulla M, Kraft Pet |
|
Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling.
Molecular genetics & genomic medicine 2019 Dec e1079. Chen Zhanhong, Sun Tian, Yang Ziyan, Zheng Yabing, Yu Ruoying, Wu Xue, Yan Junrong, Shao Yang W, Shao Xiying, Cao Wenming, Wang Xiaoj |
|
Genomic landscape of ductal carcinoma in situ and association with progression.
Breast cancer research and treatment 2019 Aug . Lin Chieh-Yu, Vennam Sujay, Purington Natasha, Lin Eric, Varma Sushama, Han Summer, Desa Manisha, Seto Tina, Wang Nicholas J, Stehr Henning, Troxell Megan L, Kurian Allison W, West Robert |
|
Comprehensive multigene mutation spectra of breast cancer patients from Northeast China obtained using the Ion Torrent sequencing platform.
Oncology reports 2019 Jul . Fan Chunni, Liu Ning, Fan Shulin, Yang Zhaoying, Ye Ning, Wang Ker |
|
Corrections to "PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab".
Annals of oncology : official journal of the European Society for Medical Oncology 2019 Jul 30 (7): 1180. Loibl S, Majewski I, Guarneri V, Nekljudova V, Holmes E, Bria E, Denkert C, Schem C, Sotiriou C, Loi S, Untch M, Conte P, Bernards R, Piccart M, von Minckwitz G, Baselga |
|
Mutation and immune profiling of metaplastic breast cancer: Correlation with survival.
PloS one 2019 14 (11): e0224726. Afkhami Michelle, Schmolze Daniel, Yost Susan E, Frankel Paul H, Dagis Andrew, Amanam Idoroenyi U, Telatar Milhan, Nguyen Kim, Yu Kim Wai, Luu Thehang, Pillai Raju, Aoun Patricia A, Mortimer Joanne, Yuan Yu |
|
Clinical-Pathologic Analysis of Breast Cancer With PIK3CA Mutations in Chinese Women.
Technology in cancer research & treatment 0 19 1533033820950832. Lian Jing, Xu En-Wei, Xi Yan-Feng, Wang Hui-Wen, Bu Peng, Wang Jin-Fen, Wang Li-X |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: